Skip to main content

Advertisement

SpringerLink
Log in

Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis

  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Abstract

It has been suggested that early postmenopausal women and patients treated with steroids should receive preventive therapy (calcium, vitamin D, vitamin D analogs, estrogens, or bisphosphonates) to preserve their bone mineral density (BMD) and to avoid fragility fractures. We designed the present study to compare the effects of native vitamin D to its hydroxylated analogs alfacalcidol 1-α(OH)D and calcitriol 1,25(OH)2D. All randomized, controlled, double-blinded trials comparing oral native vitamin D and its analogs, alfacalcidol or calcitriol, to placebo or head-to-head trials in primary or corticosteroids-induced osteoporosis were included in the meta-analysis. Sources included the Cochrane Controlled Trials Register, EMBASE, MEDLINE, and a hand search of abstracts and references lists. The study period January 1985 to January 2003. Data were abstracted by two investigators, and methodological quality was assessed in a similar manner. Heterogeneity was extensively investigated. Results were expressed as effect-size (ES) for bone loss and as rate difference (RD) for fracture while allocated to active treatment or control. Publication bias was investigated. Fourteen studies of native vitamin D, nine of alfacalcidol, and ten of calcitriol fit the inclusion criteria. The two vitamin D analogs appeared to exert a higher preventive effect on bone loss and fracture rates in patients not exposed to glucocorticoids. With respect to BMD, vitamin D analogs versus placebo studies had an ES of 0.36 (P < 0.0001), whereas native vitamin D versus placebo had an ES of 0.17 (P = 0.0005), the interclass difference being highly significant (ANOVA-1, P < 0.05). When restricted to the lumbar spine, this intertreatment difference remained significant: ES = 0.43 (P = 0.0002) for vitamin D analogs and ES = 0.21 (P = 0.001) for native vitamin D (analysis of variance [ANOVA-1], P = 0.047). There were no significant differences regarding their efficacies on other measurement sites (ANOVA-1, P = 0.36). When comparing the adjusted global relative risks for fracture when allocated to vitamin D analogs or native vitamin D, alfacalcidol and calcitriol provided a more marked preventive efficacy against fractures: RD = 10% (95% Confidence interval [CI-2] to 17) compared to RD = 2% (95% CI, 1 to 2), respectively. The analysis of the spinal and nonspinal showed that fracture rates differed between the two classes, thereby confirming the benefits of vitamin D analogs, with significant 13.4% (95% CI 7.7 to 19.8) and. 6% (95% CI 1 to 12) lower fracture rates for vitamin D analogs, respectively. In patients receiving corticosteroid therapy, both treatments provided similar global ESs for BMD: ES = 0.38 for vitamin D analogs and ES = 0.41 for native vitamin D (ANOVA-1, P = 0.88). When restriced to spinal BMD, D analogs provided significant effects, whereas native vitamin D did not: ES = 0.43 (P < 0.0001) and ES = 0.33 (P = 0.21), respectively. The intertreatment difference was nonsignificant (ANOVA-1, P = 0.52). Neither D analogs for native vitamin D significantly prevented fractures in this subcategory of patients: RD = 2.6 (95%CI, −9.5 to 4.3) and RD = 6.4 (95%CI, −2.3 to 10), respectively. In head-to-head studies comparing D analogs and native vitamin D in patients receiving corticosteroids, significant effects favoring D analogs were found for femoral neck BMD: ES = 0.31 at P = 0.02 and spinal fractures: RD = 15% (95%CI, 6.5 to 25). Publication bias was not significant. Our analysis demonstrates a superiority of the D analogs atfacalcidol and calcitriol in preventing bone loss and spinal fractures in primary osteoporosis, including postmenopausal women. In corticosteroid-induced osteoporosis, the efficacy of D analogs differed depending on the comparative approach: indirect comparisons led to nonsignificant differences, whereas direct comparison did provide significant differences. In this setting, D analogs seem to prevent spinal fractures to a greater extent than do native vitamin D, but this assumption should be confirmed on a comprehensive basis in multiarm studies including an inactive comparator.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. WJ Gillespie A Avenell DA Henry DL O’Connell (2001) ArticleTitleVitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis Cochrane Database Syst Rev 1 CD000227 Occurrence Handle11279685

    PubMed  Google Scholar 

  2. HJ Hauselmann R Rizzoli (2003) ArticleTitleA comprehensive review of treatments for postmenopausal osteoporosis Osteoporos Int 14 2–12 Occurrence Handle10.1007/s00198-002-1301-3 Occurrence Handle1:STN:280:DC%2BD3s%2Fms1OrtA%3D%3D Occurrence Handle12577179

    Article  CAS  PubMed  Google Scholar 

  3. A Cranney G Guyatt L Griffith G Wells (2002) ArticleTitleIX: Summary of meta-analyses of therapies for postmenopausal osteoporosis Endocr Rev 23 570–578 Occurrence Handle10.1210/er.2001-9002 Occurrence Handle1:CAS:528:DC%2BD38Xnt1Whs78%3D Occurrence Handle12202472

    Article  CAS  PubMed  Google Scholar 

  4. E Padimitropoulos G Wells B Shea W Gillespie (2002) ArticleTitleVIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women Endocr Rev 23 560–569 Occurrence Handle10.1210/er.2001-8002 Occurrence Handle12202471

    Article  PubMed  Google Scholar 

  5. E Papadimitropoulos B Shea G Wells P Tugwell et al. (2002) ArticleTitleVitamin D with or without calcium for treating osteoporosis in postmenopausal women Cochrane Database Syst Rev . .–569

    Google Scholar 

  6. KH Lau DJ Baylink (1999) ArticleTitleVitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy Calcif Tissue Int 65 295–306 Occurrence Handle10.1007/s002239900702 Occurrence Handle1:CAS:528:DyaK1MXmvFWqsLY%3D Occurrence Handle10485982

    Article  CAS  PubMed  Google Scholar 

  7. KS Tsai H Heath SuffixIII R Kumar BL Riggs (1984) ArticleTitleImpaired vitamin D metabolism with aging in women: possible role in pathogenesis of senile osteoporosis J Clin Invest 73 1668–1672 Occurrence Handle1:CAS:528:DyaL2cXkt1Wls7w%3D Occurrence Handle6327768

    CAS  PubMed  Google Scholar 

  8. F Scopacasa JM Wishart M Horowitz (2004) ArticleTitleRelation between calcium absorption and serum calcitriol in normal men: evidence for age-related intestinal resistance to calcitriol Eur J Clin Nutr 58 264–269 Occurrence Handle10.1038/sj.ejcn.1601777 Occurrence Handle1:CAS:528:DC%2BD2cXntlegtQ%3D%3D Occurrence Handle14749746

    Article  CAS  PubMed  Google Scholar 

  9. S Pattanaungkul BL Riggs AL Yergey (2000) ArticleTitleRelationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action J Clin Endocrinol Metab 85 4023–4027 Occurrence Handle10.1210/jc.85.11.4023 Occurrence Handle1:CAS:528:DC%2BD3cXotlWntLk%3D Occurrence Handle11095427

    Article  CAS  PubMed  Google Scholar 

  10. K Dickersin R Scherer C Lefebvre (1994) ArticleTitleIdentifying the relevant studies for systematic reviews BMJ 309 1286–1291 Occurrence Handle1:STN:280:ByqC1MrksVw%3D Occurrence Handle7718048

    CAS  PubMed  Google Scholar 

  11. AR Jadad RA Moore D Carroll C Jenkinson (1996) ArticleTitleAssessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1–12 Occurrence Handle10.1016/0197-2456(95)00134-4 Occurrence Handle1:STN:280:BymA3cfksFw%3D Occurrence Handle8721797

    Article  CAS  PubMed  Google Scholar 

  12. M Egger GD Smith M Schneider C Minder (1997) ArticleTitleBias in meta-analysis detected by a simple, graphical test BMJ 315 629–634 Occurrence Handle1:STN:280:ByiH2MnmtVI%3D Occurrence Handle9310563

    CAS  PubMed  Google Scholar 

  13. MC Chapuy ME Arlot PD Delmas PJ Meunier (1994) ArticleTitleEffect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women BMJ 308 1081–1082 Occurrence Handle1:STN:280:ByuB38jmsV0%3D Occurrence Handle8173430

    CAS  PubMed  Google Scholar 

  14. M Komulainen H Kröger MT Tuppurainen A-M Heikkinen E Alhava et al. (1998) ArticleTitleHRT and vitamin D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial Maturitas 31 45–54 Occurrence Handle10.1016/S0378-5122(98)00085-1 Occurrence Handle1:CAS:528:DyaK1MXht1Wqurc%3D Occurrence Handle10091204

    Article  CAS  PubMed  Google Scholar 

  15. M Komulainen H Kröger MT Tuppurainen A-M Heikkinen E Alhava et al. (1999) ArticleTitlePrevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial J Clin Endocrinol Metab 84 546–552 Occurrence Handle10.1210/jc.84.2.546 Occurrence Handle1:CAS:528:DyaK1MXhtVCitLw%3D Occurrence Handle10022414

    Article  CAS  PubMed  Google Scholar 

  16. M Pfeifer B Begerow HW Minne C Abrams D Nachtigall C Hansen (2000) ArticleTitleEffects of a short-term vitamin D and calcium supplementation on body smay and secondary hyperparathyroidism in elderly women J Bone Miner Res 15 1113–1118 Occurrence Handle1:CAS:528:DC%2BD3cXktFKhurs%3D Occurrence Handle10841179

    CAS  PubMed  Google Scholar 

  17. B Dawson-Hughes GE Dallal EA Krall S Harris LJ Sokoll G Falconer (1991) ArticleTitleEffect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women Ann Intern Med 115 505–512 Occurrence Handle1:CAS:528:DyaK38XisFCmsLw%3D Occurrence Handle1883119

    CAS  PubMed  Google Scholar 

  18. B Dawson-Hughes SS Harris EA Krall GE Dallal (1997) ArticleTitleEffect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older N Engl J Med 337 670–676 Occurrence Handle10.1056/NEJM199709043371003 Occurrence Handle1:CAS:528:DyaK2sXmt1Wqtbk%3D Occurrence Handle9278463

    Article  CAS  PubMed  Google Scholar 

  19. HE Meyer GB Smedshaug E Kvaavik JA Falch A Tverdal JI Pedersen (2002) ArticleTitleCan vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial J Bone Miner Res 17 709–715 Occurrence Handle1:CAS:528:DC%2BD38XislCku7c%3D Occurrence Handle11918228

    CAS  PubMed  Google Scholar 

  20. P Lips WC Graafmans ME Ooms PD Bezemer LM Bouter (1996) ArticleTitleVitamin D supplementation and fracture incidence in elderly persons Ann Intern Med 124 400–406 Occurrence Handle1:STN:280:BymC2M7psVc%3D Occurrence Handle8554248

    CAS  PubMed  Google Scholar 

  21. ME Ooms JC Roos PD Bezemer WJF Vijgh ParticleVan Der LM Bouter P Lips (1995) ArticleTitlePrevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial J Clin Endocrinol Metab 80 1052–1058 Occurrence Handle10.1210/jc.80.4.1052 Occurrence Handle1:CAS:528:DyaK2MXkvFaqtbs%3D Occurrence Handle7714065

    Article  CAS  PubMed  Google Scholar 

  22. D Hunter P Major N Arden R Swaminathan T Andrew et al. (2000) ArticleTitleA randomized controlled trial of vitamin D supplementation on preventing post menopausal bone loss and modifying bone metabolism using identical twin pairs J Bone Miner Res 15 2276–2283 Occurrence Handle1:CAS:528:DC%2BD3cXnvVKltb4%3D Occurrence Handle11092410

    CAS  PubMed  Google Scholar 

  23. DP Trivedi R Doll KT Khaw (2003) ArticleTitleEffect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial BMJ 326 469–472 Occurrence Handle10.1136/bmj.326.7387.469 Occurrence Handle1:CAS:528:DC%2BD3sXisFart7Y%3D Occurrence Handle12609940

    Article  CAS  PubMed  Google Scholar 

  24. L Baeksgaard KP Andersen L Hyldstrup (1998) ArticleTitleCalcium and vitamin D supplementation increases spinal BMD in healthy, postmenopausal women Osteoporos Int 8 255–260 Occurrence Handle10.1007/s001980050062 Occurrence Handle1:CAS:528:DyaK1cXnsFGrsr8%3D Occurrence Handle9797910

    Article  CAS  PubMed  Google Scholar 

  25. LM Buckley ES Leib KS Cartularo PM Vacek SM Cooper (1996) ArticleTitleCalcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis Ann Intern Med 125 961–968 Occurrence Handle1:CAS:528:DyaK2sXisFOnug%3D%3D Occurrence Handle8967706

    CAS  PubMed  Google Scholar 

  26. JD Adachi WG Bensen F Bianchi A Cividino S Pillersdorf et al. (1996) ArticleTitleVitamin D and calcium in the prevention of corticosteroid induced osteoporosis : a 3 year followup J Rheum 23 995–1000 Occurrence Handle1:CAS:528:DyaK28Xkt1Kjtbk%3D Occurrence Handle8782129

    CAS  PubMed  Google Scholar 

  27. CN Bernstein LL Seeger PA Anton L Artinian S Geffrey et al. (1996) ArticleTitleA randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study Aliment Pharmacol Ther 10 777–786 Occurrence Handle10.1046/j.1365-2036.1996.63205000.x Occurrence Handle1:CAS:528:DyaK28Xmslajsr8%3D Occurrence Handle8899087

    Article  CAS  PubMed  Google Scholar 

  28. T Ushiroyama S Okamura A Ikeda M Ueki (1995) ArticleTitleEfficacy of ipriflavone and 1α vitamin D therapy for the cessation of vertebral bone loss Int J Gynecol Obstet 48 283–288 Occurrence Handle10.1016/0020-7292(94)02280-C Occurrence Handle1:STN:280:ByqA3c7gs10%3D

    Article  CAS  Google Scholar 

  29. Y Hayashi T Fujita T Inoue (1992) ArticleTitleDecrease of vertebral fracture in osteoporosis by administration of 1α-hydroxy-vitamin D3 J Bone Min Res 10 184–188

    Google Scholar 

  30. P Lakatos Z Nagy L Kiss C Horvath I Takacs et al. (2000) ArticleTitlePrevention of corticosteroid-induced osteoporosis by alfacalcidol Z Rheumatol 59 IssueIDsuppl1 48–52 Occurrence Handle10.1007/s003930070040 Occurrence Handle10769437

    Article  PubMed  Google Scholar 

  31. J Menczel J Foldes R Steinberg I Leichter B Shalita et al. (1994) ArticleTitleAlfacalcidol(Alpha D3) and calcium in osteoporosis Clin Orthop 300 241–247 Occurrence Handle8131343

    PubMed  Google Scholar 

  32. H Orimo M Shiraki Y Hayashi T Hoshino T Onaya (1994) ArticleTitleEffects of 1α-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis Calcif Tissue Int 54 370–376 Occurrence Handle10.1007/BF00305521 Occurrence Handle1:STN:280:ByuA2c%2Fks1U%3D Occurrence Handle8062152

    Article  CAS  PubMed  Google Scholar 

  33. JY Reginster D Kuntz W Verdicht M Wouters L Guillevin et al. (1999) ArticleTitleProphylactic use of alfacalcidol in corticosteroid-induced osteoporosis Bone 9 75–81 Occurrence Handle1:CAS:528:DyaK1MXitVegsb8%3D

    CAS  Google Scholar 

  34. Y Sato S Manabe H Kuno K Oizumi (1999) ArticleTitleAmelioration of osteopenia and hypovitaminosis D by 1a-hydroxyvitamin D3 in elderly patients with Parkinson’s disease J Neurosurg Psychiatry 66 64–68 Occurrence Handle1:STN:280:DyaK1M7gtFGntw%3D%3D

    CAS  Google Scholar 

  35. Y Sato H Maruoka K Oizumi (1997) ArticleTitleAmelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1a-hydroxyvitamin D3 and calcium supplementation Stroke 28 736–739 Occurrence Handle1:CAS:528:DyaK2sXislyhs7k%3D Occurrence Handle9099188

    CAS  PubMed  Google Scholar 

  36. M Shiraki K Kushida K Yamazaki T Nagai T Inoue H Orimo (1996) ArticleTitleEffects of 2 year’s treatment of osteoporosis with 1a-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study Endocr J 43 211–220 Occurrence Handle1:CAS:528:DyaK2sXhvFersLg%3D Occurrence Handle9026268

    CAS  PubMed  Google Scholar 

  37. JF Aloia A Vaswani JK Yeh K Ellis S Yasumura S Cohn (1988) ArticleTitleCalcitriol in the treatment of postmenopausal osteoporosis Am J Med 84 401–408 Occurrence Handle10.1016/0002-9343(88)90259-8 Occurrence Handle1:STN:280:BieC287htV0%3D Occurrence Handle3279769

    Article  CAS  PubMed  Google Scholar 

  38. PR Ebeling JD Wark S Yeung C Poon N Salehi et al. (2001) ArticleTitleEffects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-years randomized, double blind, double placebo study J Clin Endocr Metab 86 4096–4103 Occurrence Handle10.1210/jc.86.9.4098

    Article  Google Scholar 

  39. JC Gallagher BL Riggs RR Recker D Goldgar (1989) ArticleTitleThe effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency Soc Exp Biol Med . 287–292

    Google Scholar 

  40. JC Gallagher SE Fowler JR Detter SS Sherman (2001) ArticleTitleCombination treatment with estrogen and calcitriol in the prevention of age-related bone loss J Clin Endocrinol Metab 86 3618–3628 Occurrence Handle10.1210/jc.86.8.3618 Occurrence Handle1:CAS:528:DC%2BD3MXlvFekt7s%3D Occurrence Handle11502787

    Article  CAS  PubMed  Google Scholar 

  41. JC Gallagher D Goldgar (1990) ArticleTitleTreatment of postmenopausal osteoporosis with high doses of synthetic calcitriol Ann Intern Med 113 649–655 Occurrence Handle1:STN:280:By6D38znvFQ%3D Occurrence Handle2221645

    CAS  PubMed  Google Scholar 

  42. I Lambrinoudaki DT Chan CS Lau RW Wong SS Yeung AW Kung (2000) ArticleTitleEffect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double-blind, placebo controlled study J Rheumatol 27 1759–1765 Occurrence Handle1:CAS:528:DC%2BD3cXltlKqsLY%3D Occurrence Handle10914864

    CAS  PubMed  Google Scholar 

  43. P Sambrook J Birmingham P Kelly S Kempler T Nguyen et al. (1993) ArticleTitlePrevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin N Engl J Med 328 1747–1752 Occurrence Handle10.1056/NEJM199306173282404 Occurrence Handle1:STN:280:ByyB28fjsVA%3D Occurrence Handle7684512

    Article  CAS  PubMed  Google Scholar 

  44. P Sambrook NK Henderson A Keogh P Maodonald A Glanville P Spratt (2000) ArticleTitleEffect of calcitriol on bone loss after cardiac or lung transplantation J Bone Min Res 15 1818–1824 Occurrence Handle1:CAS:528:DC%2BD3cXmsF2mtLk%3D

    CAS  Google Scholar 

  45. MW Tilyard GFS Spears J Thomson S Dovey (1992) ArticleTitleTreatment of postmenopausal osteoporosis with calcitriol and calcium N Engl J Med 326 357–362 Occurrence Handle1:STN:280:By2C3cjit1M%3D Occurrence Handle1729617

    CAS  PubMed  Google Scholar 

  46. HU Stempfle C Werner S Echtler U Wehr WA Rambeck et al. (1999) ArticleTitlePrevention of osteoporosis after cardiac transplantation Transplantation 68 523–530 Occurrence Handle10.1097/00007890-199908270-00014 Occurrence Handle1:STN:280:DyaK1MvgvVarug%3D%3D Occurrence Handle10480411

    Article  CAS  PubMed  Google Scholar 

  47. Ringe JD. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis Unpublished data.

  48. PN Sambrook M Kotowicz P Nash CB Styles V Naganathan et al. (2003) ArticleTitlePrevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium J Bone Min Res 18 919–924 Occurrence Handle1:CAS:528:DC%2BD3sXjslahs7w%3D

    CAS  Google Scholar 

  49. HC Bucher GH Guyatt L Griffith SD Walter (1997) ArticleTitleThe results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials J Clin Epidemiol 50 683–691 Occurrence Handle10.1016/S0895-4356(97)00049-8 Occurrence Handle1:STN:280:ByiA1MzotlU%3D Occurrence Handle9250266

    Article  CAS  PubMed  Google Scholar 

  50. F Song DG Altman AM Glenny JJ Deeks (2003) ArticleTitleValidity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses BMJ 326 472 Occurrence Handle10.1136/bmj.326.7387.472 Occurrence Handle12609941

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Public Health, Epidemiology and Health Economics, University of Liège; WHO Collaborating Center on Public Health Aspects of Osteoarticular Disorders, Liège, Belgium

    F. Richy, O. Bruyere, O. Ethgen & J.-Y. Reginster

  2. Metabolic Bone Disease Unit, University Clinic Balgrist, Zurich, Switzerland

    E. Schacht

  3. Robert Wood Johnson Clinical Scholars Program, UNC-Chapel Hill, Chapel Hill, NC, USA

    M. Gourlay

Authors
  1. F. Richy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Schacht
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Bruyere
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Ethgen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Gourlay
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J.-Y. Reginster
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Richy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richy, F., Schacht, E., Bruyere, O. et al. Vitamin D Analogs Versus Native Vitamin D in Preventing Bone Loss and Osteoporosis-Related Fractures: A Comparative Meta-analysis. Calcif Tissue Int 76, 176–186 (2005). https://doi.org/10.1007/s00223-004-0005-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-004-0005-4

Keywords

Search

Navigation